BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37626035)

  • 1. EIF4A3-mediated circ_0042881 activates the RAS pathway via miR-217/SOS1 axis to facilitate breast cancer progression.
    Ju C; Zhou M; Du D; Wang C; Yao J; Li H; Luo Y; He F; He J
    Cell Death Dis; 2023 Aug; 14(8):559. PubMed ID: 37626035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EIF4A3-induced circ_0084615 contributes to the progression of colorectal cancer via miR-599/ONECUT2 pathway.
    Jiang Z; Tai Q; Xie X; Hou Z; Liu W; Yu Z; Liang Z; Chen S
    J Exp Clin Cancer Res; 2021 Jul; 40(1):227. PubMed ID: 34253241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsa_circ_0009092/miR-665/NLK signaling axis suppresses colorectal cancer progression via recruiting TAMs in the tumor microenvironment.
    Song J; Liu Q; Han L; Song T; Huang S; Zhang X; He Q; Liang C; Zhu S; Xiong B
    J Exp Clin Cancer Res; 2023 Nov; 42(1):319. PubMed ID: 38008713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. eIF4A3-induced circWAC promotes breast cancer progression through mediating miR-599/E2F3 axis.
    Huang WH; Yang Q; Zhang C
    Kaohsiung J Med Sci; 2022 Apr; 38(4):321-335. PubMed ID: 34989110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EIF4A3-regulated circ_0087429 can reverse EMT and inhibit the progression of cervical cancer via miR-5003-3p-dependent upregulation of OGN expression.
    Yang M; Hu H; Wu S; Ding J; Yin B; Huang B; Li F; Guo X; Han L
    J Exp Clin Cancer Res; 2022 May; 41(1):165. PubMed ID: 35513835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EIF4A3-mediated hsa_circ_0088088 promotes the carcinogenesis of breast cancer by sponging miR-135-5p.
    Liu Q; Dong H
    J Biochem Mol Toxicol; 2021 Nov; 35(11):e22909. PubMed ID: 34463003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
    Xu JH; Wang Y; Xu D
    Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA.
    Mao S; Zhang W; Yang F; Guo Y; Wang H; Wu Y; Wang R; Maskey N; Zheng Z; Li C; Ma W; Zhang J; Yan Y; Yao X
    J Exp Clin Cancer Res; 2021 Oct; 40(1):336. PubMed ID: 34696782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0030042 regulates abnormal autophagy and protects atherosclerotic plaque stability by targeting eIF4A3.
    Yu F; Zhang Y; Wang Z; Gong W; Zhang C
    Theranostics; 2021; 11(11):5404-5417. PubMed ID: 33859754
    [No Abstract]   [Full Text] [Related]  

  • 10. Circular RNA hsa_circ_0001785 inhibits the proliferation, migration and invasion of breast cancer cells in vitro and in vivo by sponging miR-942 to upregulate SOCS3.
    Li Z; Zheng J; Lin W; Weng J; Hong W; Zou J; Zhang T; Ye C; Chen Y
    Cell Cycle; 2020 Nov; 19(21):2811-2825. PubMed ID: 33054543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
    Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
    Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa_circ_0005273 facilitates breast cancer tumorigenesis by regulating YAP1-hippo signaling pathway.
    Wang X; Ji C; Hu J; Deng X; Zheng W; Yu Y; Hua K; Zhou X; Fang L
    J Exp Clin Cancer Res; 2021 Jan; 40(1):29. PubMed ID: 33436041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hsa_circ_0101119 facilitates the progression of cervical cancer via an interaction with EIF4A3 to inhibit TCEAL6 expression.
    Sui X; Wang Y; Liu H
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YY1 and eIF4A3 are mediators of the cell proliferation, migration and invasion in cholangiocarcinoma promoted by circ-ZNF609 by targeting miR-432-5p to regulate LRRC1.
    Guan C; Liu L; Zhao Y; Zhang X; Liu G; Wang H; Gao X; Zhong X; Jiang X
    Aging (Albany NY); 2021 Dec; 13(23):25195-25212. PubMed ID: 34898474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA hsa_circ_0008039 promotes proliferation, migration and invasion of breast cancer cells through upregulating CBX4 via sponging miR-515-5p.
    Huang FJ; Dang JQ; Zhang S; Cheng ZY
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1887-1898. PubMed ID: 32141558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548.
    Jin M; Lu S; Wu Y; Yang C; Shi C; Wang Y; Huang G
    J Exp Clin Cancer Res; 2020 Sep; 39(1):186. PubMed ID: 32928266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR-140-3p/SKA2 axis.
    Dou D; Ren X; Han M; Xu X; Ge X; Gu Y; Wang X; Zhao S
    Mol Oncol; 2021 Feb; 15(2):697-709. PubMed ID: 33244865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of circ_0102273 inhibits the proliferation, metastasis and glycolysis of breast cancer through miR-1236-3p/PFKFB3 axis.
    Yu H; Luo H; Liu X
    Anticancer Drugs; 2022 Apr; 33(4):323-334. PubMed ID: 35266884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway.
    Chen Y; Wang D; Shu T; Sun K; Zhao J; Wang M; Huang Y; Wang P; Zheng H; Cai Z; Yang Z
    Bioengineered; 2021 Dec; 12(2):11410-11422. PubMed ID: 34889689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_0001667 Promotes Adriamycin Resistance and Malignant Progression via Targeting the miR-193a-5p/Rap2A Molecular Axis in Breast Cancer.
    Xu S; Luo W; Li M; Li Q; Hong W; Gao Y; Yang J; Song H; Chen L; Yang Y; Yang C
    Clin Breast Cancer; 2023 Jan; 23(1):71-83. PubMed ID: 36289041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.